Download PDF
Am J Perinatol 2021; 38(11): 1142-1149
DOI: 10.1055/s-0040-1710554
Original Article

Early Gut Microbiota Changes in Preterm Infants with Bronchopulmonary Dysplasia: A Pilot Case–Control Study

Shan-Ming Chen
1   Department of Pediatrics, Chung Shan Medical University Hospital, Taichung, Taiwan
2   Department of Pediatrics, School of Medicine, Chung Shan Medical University, Taichung, Taiwan
,
Ching-Pin Lin
3   Division of Hepatology and Gastroenterology, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
4   Institute of Biochemistry, Microbiology and Immunology, Chung Shan Medical University, Taichung, Taiwan
,
Ming-Shiou Jan 
4   Institute of Biochemistry, Microbiology and Immunology, Chung Shan Medical University, Taichung, Taiwan
5   Immunology Research Center, Chung Shan Medical University, Taichung, Taiwan
6   Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Chung Shan Medical University, Taichung, Taiwan
› Author Affiliations Funding This study was supported by research grants from Chung Shan Medical University Hospital, Taiwan (CSH-2016-C-30).
› Further Information
    Permissions and Reprints

Abstract

Objective Bronchopulmonary dysplasia (BPD) is a complex chronic lung disease that primarily affects premature or critically ill infants. This pilot study investigated early changes in gut microbiota composition in BPD patients and explored the potential risk factors associated with these changes.

Study Design Preterm infants admitted to our neonatal intensive care unit with a gestational age of 26 to 32 weeks were prospectively surveyed and eligible for stool collection on days 7 and 28 of postnatal age between February 2016 and June 2017. A 16S rRNA sequencing approach was applied to compare the gut microbiota composition between the BPD group and controls. Multiple linear regression analysis was used to identify the predictor variables.

Results Eight subjects in the BPD group and 10 subjects in the preterm group were analyzed during the observation period. Actinobacteria, Proteobacteria, Bacteroidetes, and Firmicutes were the four dominant bacteria phyla of intestinal microflora. A significantly lower diversity of gut microbiota was observed in the BPD group compared with the preterm group on day 28 (number of observed operational taxonomic units, p = 0.034; abundance-based coverage estimator, p = 0.022; Shannon index, p = 0.028). Multiple linear regression analysis revealed that high Neonatal Therapeutic Intervention Scoring System score (≧19) at 24 hours was statistically significant in predicting the proportion of aerobic with facultative anaerobic bacteria on day 28 (p = 0.002).

Conclusion Infants with BPD are prone to develop gut dysbiosis in early life. A higher severity of illness and treatment intensity may indicate a higher risk of disrupting an anaerobic environment in the gut during the first month of life.

Key Points

  • BPD patients are prone to develop gut dysbiosis.

  • Lower diversity of gut microbiota.

  • Higher risk of disrupting anaerobic environment.

Keywords

bronchopulmonary dysplasia - dysbiosis - gut microbiota - next-generation sequencing - neonatal intensive care unit


Publication History

Received: 22 September 2019

Accepted: 09 April 2020

Article published online:
23 May 2020

© 2020. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Northway Jr WH, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 1967; 276 (07) 357-368
    CrossrefPubMedGoogle Scholar
  • 2 Poets CF, Lorenz L. Prevention of bronchopulmonary dysplasia in extremely low gestational age neonates: current evidence. Arch Dis Child Fetal Neonatal Ed 2018; 103 (03) F285-F291
    CrossrefPubMedGoogle Scholar
  • 3 Stoll BJ, Hansen NI, Bell EF. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA 2015; 314 (10) 1039-1051
    CrossrefPubMedGoogle Scholar
  • 4 Davidson LM, Berkelhamer SK. Bronchopulmonary dysplasia: chronic lung disease of infancy and long-term pulmonary outcomes. J Clin Med 2017; 6 (01) 4
    CrossrefPubMedGoogle Scholar
  • 5 Pammi M, Lal CV, Wagner BD. et al. Airway microbiome and development of bronchopulmonary dysplasia in preterm infants: a systematic review. J Pediatr 2019; 204: 126-133.e2
    CrossrefPubMedGoogle Scholar
  • 6 Pietrzyk JJ, Kwinta P, Wollen EJ. et al. Gene expression profiling in preterm infants: new aspects of bronchopulmonary dysplasia development. PLoS One 2013; 8 (10) e78585
    CrossrefPubMedGoogle Scholar
  • 7 Ryan FJ, Drew DP, Douglas C. et al. Changes in the composition of the gut microbiota and the blood transcriptome in preterm infants at less than 29 weeks gestation diagnosed with bronchopulmonary dysplasia. mSystems 2019; 4 (05) e00484-e19
    PubMedGoogle Scholar
  • 8 Tripathi S, Malik G. Neonatal sepsis: past, present and future: a review article. Internet J Med Update 2010; 5: 45-54
    PubMedGoogle Scholar
  • 9 Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163 (07) 1723-1729
    CrossrefPubMedGoogle Scholar
  • 10 Arthur R. The neonatal chest X-ray. Paediatr Respir Rev 2001; 2 (04) 311-323
    PubMedGoogle Scholar
  • 11 Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978; 92 (04) 529-534
    CrossrefPubMedGoogle Scholar
  • 12 Lee JS, Polin RA. Treatment and prevention of necrotizing enterocolitis. Semin Neonatol 2003; 8 (06) 449-459
    CrossrefPubMedGoogle Scholar
  • 13 Gray JE, Richardson DK, McCormick MC, Workman-Daniels K, Goldmann DA. Neonatal therapeutic intervention scoring system: a therapy-based severity-of-illness index. Pediatrics 1992; 90 (04) 561-567
    CrossrefPubMedGoogle Scholar
  • 14 Alam MM, Saleem AF, Shaikh AS, Munir O, Qadir M. Neonatal sepsis following prolonged rupture of membranes in a tertiary care hospital in Karachi, Pakistan. J Infect Dev Ctries 2014; 8 (01) 67-73
    CrossrefPubMedGoogle Scholar
  • 15 Dice JE, Bhatia J. Patent ductus arteriosus: an overview. J Pediatr Pharmacol Ther 2007; 12 (03) 138-146
    PubMedGoogle Scholar
  • 16 SIFT Investigators Group. Early enteral feeding strategies for very preterm infants: current evidence from Cochrane reviews. Arch Dis Child Fetal Neonatal Ed 2013; 98 (06) F470-F472
    CrossrefPubMedGoogle Scholar
  • 17 Klindworth A, Pruesse E, Schweer T. et al. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res 2013; 41 (01) e1
    CrossrefPubMedGoogle Scholar
  • 18 Magoč T, Salzberg SL. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics 2011; 27 (21) 2957-2963
    CrossrefPubMedGoogle Scholar
  • 19 Edgar RC. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods 2013; 10 (10) 996-998
    CrossrefPubMedGoogle Scholar
  • 20 Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol 2007; 73 (16) 5261-5267
    CrossrefPubMedGoogle Scholar
  • 21 Yilmaz P, Parfrey LW, Yarza P. et al. The SILVA and “All-species Living Tree Project (LTP)” taxonomic frameworks. Nucleic Acids Res 2014; 42 (Database issue): D643-D648
    CrossrefPubMedGoogle Scholar
  • 22 Caporaso JG, Kuczynski J, Stombaugh J. et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 2010; 7 (05) 335-336
    CrossrefPubMedGoogle Scholar
  • 23 Warner BB, Hamvas A. Lungs, microbes and the developing neonate. Neonatology 2015; 107 (04) 337-343
    CrossrefPubMedGoogle Scholar
  • 24 Berkhout DJC, Niemarkt HJ, Benninga MA. et al. Development of severe bronchopulmonary dysplasia is associated with alterations in fecal volatile organic compounds. Pediatr Res 2018; 83 (02) 412-419
    CrossrefPubMedGoogle Scholar
  • 25 Ranucci G, Buccigrossi V, de Freitas MB, Guarino A, Giannattasio A. Early-life intestine microbiota and lung health in children. J Immunol Res 2017; 2017: 8450496
    CrossrefPubMedGoogle Scholar
  • 26 Gritz EC, Bhandari V. The human neonatal gut microbiome: a brief review. Front Pediatr 2015; 3: 17
    PubMedGoogle Scholar
  • 27 Rizzatti G, Lopetuso LR, Gibiino G, Binda C, Gasbarrini A. Proteobacteria: a common factor in human diseases. BioMed Res Int 2017; 2017: 9351507
    CrossrefPubMedGoogle Scholar
  • 28 Shin NR, Whon TW, Bae JW. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol 2015; 33 (09) 496-503
    CrossrefPubMedGoogle Scholar
  • 29 Talarico ST, Santos FE, Brandt KG, Martinez MB, Taddei CR. Anaerobic bacteria in the intestinal microbiota of Brazilian children. Clinics (São Paulo) 2017; 72 (03) 154-160
    CrossrefPubMedGoogle Scholar
  • 30 Dhebri AR, Afify SE. Free gas in the peritoneal cavity: the final hazard of diathermy. Postgrad Med J 2002; 78 (922) 496-497
    CrossrefPubMedGoogle Scholar
  • 31 Jaile JC, Levin T, Wung JT, Abramson SJ, Ruzal-Shapiro C, Berdon WE. Benign gaseous distension of the bowel in premature infants treated with nasal continuous airway pressure: a study of contributing factors. AJR Am J Roentgenol 1992; 158 (01) 125-127
    CrossrefPubMedGoogle Scholar
  • 32 Friedman ES, Bittinger K, Esipova TV. et al. Microbes vs. chemistry in the origin of the anaerobic gut lumen. Proc Natl Acad Sci U S A 2018; 115 (16) 4170-4175
    CrossrefPubMedGoogle Scholar
  • 33 Wemhöner A, Ortner D, Tschirch E, Strasak A, Rüdiger M. Nutrition of preterm infants in relation to bronchopulmonary dysplasia. BMC Pulm Med 2011; 11: 7
    CrossrefPubMedGoogle Scholar